Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.

@article{Belt1998ReplacingIC,
  title={Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.},
  author={A G M van den Belt and Patrick M. M. Bossuyt and Martin H. Prins and Alex S. Gallus and Harry Roger B{\"u}ller},
  journal={Thrombosis and haemostasis},
  year={1998},
  volume={79 2},
  pages={259-63}
}
Two clinical trials in patients with acute deep venous thrombosis have indicated that the outpatient management with fixed-dose, subcutaneous low-molecular-weight heparin is at least as effective and safe as inpatient treatment with unfractionated intravenous heparin with respect to recurrent venous thromboembolism and major bleeding. We performed an economic evaluation alongside one of these trials to assess the cost consequences of the outpatient management strategy. Data were collected… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

Hospital versus home treatment of deep vein thrombosis in a tertiary care hospital in Saudi Arabia: Are we ready?

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society • 2013
View 2 Excerpts

Initial management of deep venous thrombosis in the outpatient setting.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists • 2008

Similar Papers

Loading similar papers…